2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1
- 15 May 2010
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 245 (1), 91-99
- https://doi.org/10.1016/j.taap.2010.02.007
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Introducing the “TCDD-Inducible AhR-Nrf2 Gene Battery”Toxicological Sciences, 2009
- CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expressionBlood, 2009
- Chemistry and Antihypertensive Effects of Tempol and Other NitroxidesPharmacological Reviews, 2008
- Hypertension, Cardiac Hypertrophy, and Impaired Vascular Relaxation Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin are Associated with Increased SuperoxideCardiovascular Toxicology, 2008
- A Critical Comparison of Murine Pathology and Epidemiological Data of TCDD, PCB126, and PeCDFToxicologic Pathology, 2007
- Suppressive Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Vascular Remodeling That Takes Place in the Normal Labyrinth Zone of Rat Placenta during Late GestationToxicological Sciences, 2006
- Aryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene BatteriesMolecular Pharmacology, 2005
- Endothelin-1–Mediated Increase in Reactive Oxygen Species and NADPH Oxidase Activity in Hearts of Aryl Hydrocarbon Receptor (AhR) Null MiceToxicological Sciences, 2005
- CYP1A2 protects against reactive oxygen production in mouse liver microsomesFree Radical Biology & Medicine, 2004
- Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesisBirth Defects Research Part A: Clinical and Molecular Teratology, 2003